000			01790 a2200529 4500
005			20250515130552.0
264		0	_c20081125
008			200811s 0 0 eng d
022			_a0007-1188
024	7		_a10.1038/bjp.2008.292 _2doi
040			_aNLM _beng _cNLM
100	1		_aWu, S Y
245	0	0	_aYC-1 induces apoptosis of human renal carcinoma A498 cells in vitro and in vivo through activation of the JNK pathway. _h[electronic resource]
260			_bBritish journal of pharmacology _cOct 2008
300			_a505-13 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aApoptosis _xdrug effects
650	0	4	_aCarcinoma, Renal Cell _xdrug therapy
650	0	4	_aCaspase 3 _xdrug effects
650	0	4	_aCaspase 8 _xdrug effects
650	0	4	_aChromatin _xdrug effects
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aEnzyme Activators _xadministration & dosage
650	0	4	_aFas Ligand Protein _xdrug effects
650	0	4	_aG1 Phase _xdrug effects
650	0	4	_aHumans
650	0	4	_aIndazoles _xadministration & dosage
650	0	4	_aJNK Mitogen-Activated Protein Kinases _xdrug effects
650	0	4	_aMale
650	0	4	_aMice
650	0	4	_aMice, Inbred BALB C
650	0	4	_aMice, Nude
650	0	4	_aPhosphorylation _xdrug effects
650	0	4	_afas Receptor _xdrug effects
700	1		_aPan, S L
700	1		_aChen, T H
700	1		_aLiao, C H
700	1		_aHuang, D Y
700	1		_aGuh, J H
700	1		_aChang, Y L
700	1		_aKuo, S C
700	1		_aLee, F Y
700	1		_aTeng, C M
773	0		_tBritish journal of pharmacology _gvol. 155 _gno. 4 _gp. 505-13
856	4	0	_uhttps://doi.org/10.1038/bjp.2008.292 _zAvailable from publisher's website
999			_c18121710 _d18121710